![]()
|
|
||||||||
(Received for publication, August 16,
1995; and in revised form, November 30, 1995) The immature erythroid J2E cell line proliferates and terminally
differentiates following erythropoietin stimulation. In contrast, the
mutant J2E-NR clone does not respond to erythropoietin by either
proliferating or differentiating. Here we show that erythropoietin can
act as a viability factor for both the J2E and J2E-NR lines, indicating
that erythropoietin-initiated maturation is separable from the
prevention of cell death. The inability of J2E-NR cells to mature in
response to erythropoietin was not due to a defect in the
erythropoietin receptor sequence, although surface receptor numbers
were reduced. Both the receptor and Janus kinase 2 were phosphorylated
after erythropoietin stimulation of J2E-NR cells. However, protein
interactions with the erythropoietin receptor and Grb2 were restricted
in the mutant cells. Subsequent investigation of several other
signaling molecules exposed numerous alterations in J2E-NR cells;
phosphorylation changes to phosphatidylinositol 3-kinase, phospholipase
C
Volume 271,
Number 7,
Issue of February 16, 1996 pp. 3453-3459
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
, p120 GAP, and mitogen-activated protein kinases (p42 and p44)
observed in erythropoietin-stimulated J2E cells were not seen in the
J2E-NR line. These data indicate that some pathways activated during
erythropoietin-induced differentiation may not be essential for the
prevention of apoptosis.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
E. Ingley, J. R. Schneider, C. J. Payne, D. J. McCarthy, K. W. Harder, M. L. Hibbs, and S. P. Klinken Csk-binding Protein Mediates Sequential Enzymatic Down-regulation and Degradation of Lyn in Erythropoietin-stimulated Cells J. Biol. Chem., October 20, 2006; 281(42): 31920 - 31929. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. S. Cull, P. A. Tilbrook, E. J. Bartlett, N. L. Brekalo, and C. M. James Type I interferon differential therapy for erythroleukemia: specificity of STAT activation Blood, April 1, 2003; 101(7): 2727 - 2735. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Lin, L. Brown, D. W. Hedley, D. L. Barber, and S. Benchimol The death-promoting activity of p53 can be inhibited by distinct signaling pathways Blood, December 1, 2002; 100(12): 3990 - 4000. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Ingley, D. Chappell, S. Y. K. Poon, M. K. Sarna, J. G. Beaumont, J. H. Williams, J. P. Stillitano, S. Tsai, P. J. Leedman, P. A. Tilbrook, et al. Thyroid Hormone Receptor-interacting Protein 1 Modulates Cytokine and Nuclear Hormone Signaling in Erythroid Cells J. Biol. Chem., November 9, 2001; 276(46): 43428 - 43434. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Tilbrook, G. A. Palmer, T. Bittorf, D. J. McCarthy, M. J. Wright, M. K. Sarna, D. Linnekin, V. S. Cull, J. H. Williams, E. Ingley, et al. Maturation of Erythroid Cells and Erythroleukemia Development Are Affected by the Kinase Activity of Lyn Cancer Res., March 1, 2001; 61(6): 2453 - 2458. [Abstract] [Full Text] |
||||
![]() |
E. Ingley, M. K. Sarna, J. G. Beaumont, P. A. Tilbrook, S. Tsai, Y. Takemoto, J. H. Williams, and S. P. Klinken HS1 Interacts with Lyn and Is Critical for Erythropoietin-induced Differentiation of Erythroid Cells J. Biol. Chem., March 10, 2000; 275(11): 7887 - 7893. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Gaffen, S. Y. Lai, G. D. Longmore, K. D. Liu, and M. A. Goldsmith Genetic Evidence for an Additional Factor Required for Erythropoietin-Induced Signal Transduction Blood, July 1, 1999; 94(1): 74 - 86. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Spadaccini, P. A. Tilbrook, M. K. Sarna, M. Crossley, J. J. Bieker, and S. P. Klinken Transcription Factor Erythroid Kruppel-like Factor (ELKF) Is Essential for the Erythropoietin-induced Hemoglobin Production but Not for Proliferation, Viability, or Morphological Maturation J. Biol. Chem., September 11, 1998; 273(37): 23793 - 23798. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. von Lindern, M. P.-v. Amelsvoort, T. van Dijk, E. Deiner, E. van den Akker, S. van Emst-de Vries, P. Willems, H. Beug, and B. Lowenberg Protein Kinase C alpha Controls Erythropoietin Receptor Signaling J. Biol. Chem., October 27, 2000; 275(44): 34719 - 34727. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Sayer, P. A. Tilbrook, A. Spadaccini, E. Ingley, M. K. Sarna, J. H. Williams, N. C. Andrews, and S. P. Klinken Ectopic Expression of Transcription Factor NF-E2 Alters the Phenotype of Erythroid and Monoblastoid Cells J. Biol. Chem., August 11, 2000; 275(33): 25292 - 25298. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |